• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·002223.SZ
Share

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Stocks

CN¥ 25.07Last Updated 11.09.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

CN¥ 3.85B

CN¥ 25.07
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., formerly known as Yuwell Medical, was established in 1998 and is headquartered in Shanghai, China. The company operates globally, manufacturing and distributing a diverse array of medical devices in both domestic and international markets. Its extensive product catalog includes sophisticated respiratory therapy solutions, such as ventilators, humidifiers, oxygen generators, nebulizers, and advanced non-invasive ventilator data management systems. Yuwell also offers comprehensive chronic disease monitoring systems, featuring sphygmomanometers, blood glucose meters, pulse oximeters, thermometers, stethoscopes, alongside general practice diagnostic tools and in-hospital blood glucose management platforms. Furthermore, the company provides cutting-edge imaging diagnosis and treatment solutions, including ultrasound diagnostic imaging, interventional, and minimally invasive technologies. Its offerings extend to infection control and disinfection products, as well as specialized ophthalmology and vision care items like microscopes, eye surgical instruments, ophthalmoscopes, synoptophores, and keratometers. Defibrillator monitors are also part of their product range. Additionally, Yuwell supplies a broad spectrum of durable medical equipment and consumables, encompassing basic and microsurgical tools, instruments for ENT and orthopedics, endoscopic devices, dental appliances, acupuncture and electronic acupuncture products, absorbable sutures, and venous indwelling needles.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 002223.SZ is 36.4 and suggests 41.7% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

11.09.2026 17:37

Inflation in the U.S. in August came in slightly above expectations. What can we expect from the Fed now?

11.09.2026 17:24

"A Recipe for Volatility": Why BofA Sees Risks in Market Calm

11.09.2026 15:00

Uber's CEO Invested $10 Million in the Company's Shares, Which Had Fallen in Price

11.09.2026 13:30

An investor from "Shorting" advised buying wine amid the dollar's decline

11.09.2026 13:11

Diesel prices in the U.S. have exceeded $6 per gallon for the first time in history

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026